194 related articles for article (PubMed ID: 34627174)
21. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
[TBL] [Abstract][Full Text] [Related]
22. Shining a light on xeroderma pigmentosum.
DiGiovanna JJ; Kraemer KH
J Invest Dermatol; 2012 Mar; 132(3 Pt 2):785-96. PubMed ID: 22217736
[TBL] [Abstract][Full Text] [Related]
23. Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect.
Fassihi H; Sethi M; Fawcett H; Wing J; Chandler N; Mohammed S; Craythorne E; Morley AM; Lim R; Turner S; Henshaw T; Garrood I; Giunti P; Hedderly T; Abiona A; Naik H; Harrop G; McGibbon D; Jaspers NG; Botta E; Nardo T; Stefanini M; Young AR; Sarkany RP; Lehmann AR
Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1236-45. PubMed ID: 26884178
[TBL] [Abstract][Full Text] [Related]
24. A 10-year follow-up of a child with mild case of xeroderma pigmentosum complementation group D diagnosed by whole-genome sequencing.
Ono R; Masaki T; Mayca Pozo F; Nakazawa Y; Swagemakers SM; Nakano E; Sakai W; Takeuchi S; Kanda F; Ogi T; van der Spek PJ; Sugasawa K; Nishigori C
Photodermatol Photoimmunol Photomed; 2016 Jul; 32(4):174-80. PubMed ID: 26993158
[TBL] [Abstract][Full Text] [Related]
25. Sunlight, Vitamin D, and Xeroderma Pigmentosum.
Martens MC; Emmert S; Boeckmann L
Adv Exp Med Biol; 2020; 1268():319-331. PubMed ID: 32918226
[TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of the XP-D gene in Italian families with patients affected by trichothiodystrophy and xeroderma pigmentosum group D.
Mondello C; Nardo T; Giliani S; Arrand JE; Weber CA; Lehmann AR; Nuzzo F; Stefanini M
Mutat Res; 1994 Mar; 314(2):159-65. PubMed ID: 7510365
[TBL] [Abstract][Full Text] [Related]
27. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes.
Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T
Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216
[TBL] [Abstract][Full Text] [Related]
28. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
29. Clinically asymptomatic xeroderma pigmentosum neurological disease in an adult: evidence for a neurodegeneration in later life caused by defective DNA repair.
Robbins JH; Brumback RA; Moshell AN
Eur Neurol; 1993; 33(3):188-90. PubMed ID: 8467834
[TBL] [Abstract][Full Text] [Related]
30. Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer: involvement of the human ERCC2 DNA repair gene.
Flejter WL; McDaniel LD; Johns D; Friedberg EC; Schultz RA
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):261-5. PubMed ID: 1729695
[TBL] [Abstract][Full Text] [Related]
31. [Xeroderma pigmentosum].
Ueda M; Ichihashi M
Nihon Rinsho; 1995 Nov; 53(11):2815-20. PubMed ID: 8538050
[TBL] [Abstract][Full Text] [Related]
32. Xeroderma pigmentosum variant with multisystem involvement.
Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
[TBL] [Abstract][Full Text] [Related]
33. Separation of protein factors that correct the defects in the seven complementation groups of xeroderma pigmentosum cells.
Tateishi S; Mori S; Sugano T; Hori N; Ohtsuka E; Yamaizumi M
J Biochem; 1995 Oct; 118(4):819-24. PubMed ID: 8576098
[TBL] [Abstract][Full Text] [Related]
34. Xeroderma Pigmentosum: A Model for Human Premature Aging.
Rizza ERH; DiGiovanna JJ; Khan SG; Tamura D; Jeskey JD; Kraemer KH
J Invest Dermatol; 2021 Apr; 141(4S):976-984. PubMed ID: 33436302
[TBL] [Abstract][Full Text] [Related]
35. Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form.
Robbins JH; Brumback RA; Mendiones M; Barrett SF; Carl JR; Cho S; Denckla MB; Ganges MB; Gerber LH; Guthrie RA
Brain; 1991 Jun; 114 ( Pt 3)():1335-61. PubMed ID: 2065254
[TBL] [Abstract][Full Text] [Related]
36. The cloned human DNA excision repair gene ERCC-1 fails to correct xeroderma pigmentosum complementation groups A through I.
van Duin M; Vredeveldt G; Mayne LV; Odijk H; Vermeulen W; Klein B; Weeda G; Hoeijmakers JH; Bootsma D; Westerveld A
Mutat Res; 1989 Mar; 217(2):83-92. PubMed ID: 2918869
[TBL] [Abstract][Full Text] [Related]
37. Progressive length-dependent polyneuropathy in xeroderma pigmentosum group A.
Tsuji Y; Ueda T; Sekiguchi K; Nishiyama M; Kanda F; Nishigori C; Toda T; Matsumoto R
Muscle Nerve; 2020 Oct; 62(4):534-540. PubMed ID: 32696477
[TBL] [Abstract][Full Text] [Related]
38. Human chromosome 15 confers partial complementation of phenotypes to xeroderma pigmentosum group F cells.
Saxon PJ; Schultz RA; Stanbridge EJ; Friedberg EC
Am J Hum Genet; 1989 Apr; 44(4):474-85. PubMed ID: 2929593
[TBL] [Abstract][Full Text] [Related]
39. Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome.
Broughton BC; Thompson AF; Harcourt SA; Vermeulen W; Hoeijmakers JH; Botta E; Stefanini M; King MD; Weber CA; Cole J
Am J Hum Genet; 1995 Jan; 56(1):167-74. PubMed ID: 7825573
[TBL] [Abstract][Full Text] [Related]
40. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum.
Lambert WC; Lambert MW
Photochem Photobiol; 2015; 91(2):475-83. PubMed ID: 25382223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
